Johnson & Johnson: Deserves A Place In Conservative Dividend Growth Portfolios
Source: SeekingAlpha
2026-03-25 21:43:44 ET
Johnson & Johnson (JNJ) is a true Dividend King with more than 60 years of consecutive dividend growth. In this uncertain market, investing in a dividend juggernaut with above-inflation long-term growth is just the medicine your portfolio needs. Conservative dividend growth investors should have the name in their portfolios....
Read the full article on Seeking Alpha
For further details see:
Johnson & Johnson: Deserves A Place In Conservative Dividend Growth Portfolios
Johnson & Johnson
NASDAQ: JNJ
JNJ Trading
0.19% G/L:
$241.985 Last:
2,796,650 Volume:
$241.19 Open:
JNJ Latest News
March 28, 2026 10:00:00 am
ICOTYDE(TM) (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once?daily pill for plaque psoriasis
March 23, 2026 05:20:00 pm
If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026
March 21, 2026 06:24:55 am
Swiss Life Asset Management Ltd Sells 26,035 Shares of Johnson & Johnson $JNJ
March 20, 2026 12:31:30 pm
Johnson & Johnson Secures FDA Approval for Icotyde to Disrupt the Oral Psoriasis Market
JNJ Stock Data
$577,845,337,264
2,385,202,151
0.01%
2802
N/A
Pharmaceuticals
Healthcare
US
New Brunswick
